Gen Z still wants ESG April 1, 2026 There's still a case for purpose over profit, not least because our Gen Z business successors are demanding it, writes Natasha Frangos.
Andy Haldane: My mission to ignite Britain’s animal spirits March 31, 2026 As the Bank of England’s chief economist, Andy Haldane had a front row seat to the maladies of UK’s sluggish economy. After a four-year stint running the RSA, he is back as president of the British Chambers of Commerce, and tells Ali Lyon business is still taxed mindlessly, over regulated, and far too risk averse. [...]
Britain is still paying a heavy price for Covid lockdowns March 31, 2026 Six years on from the first lockdown, Britain hasn’t returned to its pre-Covid path – instead becoming a high-tax, low-growth less free nation, says Alex Pugh A little over six years ago, 27m people watched UK Prime Minister Boris Johnson tell them to “stay home” to tackle the spread of coronavirus. Johnson said you should [...]
Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote March 30, 2026 Union members overwhelmingly approve strike action with 95.52% voting in favor on a 95.38% turnout, clearing the final legal hurdle after mediation ceased. Union emphasizes this is a fight against structural corporate governance issues, citing unresolved allegations concerning unfair labor practices and ESG compliance risks. Management adhered to a group-level wage guideline rather than bargaining on the basis of Samsung Biologics' own performance, exposing a lack of independent bargaining authority.
Dompé Announces First Patient Enrolled in New Study of Intranasal NGF in Cerebral Palsy March 30, 2026 Cerebral Palsy (CP) refers to a group of permanent disorders in the development of movement and posture, which causes activity limitations, and is attributed to non-progressive disturbances that occurred in the developing fetal or infant brain.1 Nerve growth factor (NGF) is a naturally-occurring protein that supports damaged nerve cells and improves nervous system signaling, Dompé is investigating whether intranasal NGF has the potential to improve movement and neurodevelopment and address underlying brain damage in people with CP. Dompé’s intranasal NGF platform builds on the Nobel Prize-winning discovery of neurobiologist Professor Rita Levi-Montalcini and biochemist Dr. Stanley Cohen.
It’s time for Farage to choose between a big and small state March 30, 2026 Reform UK can’t duck the tough choices any longer, says Eliot Wilson Some had hailed it as a symbol of a new era of politics: when Reform UK issued its manifesto for the 2024 general election, with its impressive strike rate of eight photographs of Nigel Farage in a slender 28 pages, it included a [...]
How the square mile is helping make London one of world’s the best cities March 30, 2026 London has been named a 2026 Laureate of one of the world’s most prominent awards in urban planning and city development, the Lee Kuan Yew World City Prize, says Chris Hayward March 2026 has proved an exemplary month for the City of London’s urban built environment. After a successful pitch to global investors and developers [...]
Bureau Veritas and Trade Technologies Join Forces to Streamline Global Trade Operations March 30, 2026 Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), through its Swiss branch Government Services Division, is pleased to announce a strategic agreement with Trade Technologies, the leading provider of trade finance automation, connectivity and transaction management services. This collaboration is a significant step toward reducing the complexities of international trade operations, [...]
Arbuthnot chief: High street banks’ push into wealth is no threat March 30, 2026 One of London’s oldest private banking institutions has sounded off on the influx of the British banking giants looking to grab a slice of the wealth management pie. Andrew Salmon, the boss of Arbuthnot Latham, told City AM that when big bank rivals attempt to go “stratospheric” with their thresholds, it would benefit from its [...]
Angelalign Technology (6699.HK) Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth March 27, 2026 Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD [...]